DJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ rose 1.68% to $134.28 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.78% to 6,389.45 and the Dow Jones Industrial Average rising 0.47% to 44,175.61.
This was the stock's sixth consecutive day of gains.
Abbott Laboratories closed 4.92% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.05% to $173.33, Pfizer Inc. $(PFE)$ rose 1.44% to $24.58, and Merck & Co. Inc. $(MRK)$ rose 0.40% to $80.69.
Trading volume (5.0 M) remained 1.7 million below its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 08, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。